This biotech powerhouse could maintain its strength for the long term.

In the throes of a "bearish-to-bullish" reversal, the stock exhibits bullish price-volume correlation and impressive relative ...

In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...

Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

While access to capital funding remains elusive for many biotechs and the macroeconomic environment remains uncertain due to tariffs, M&A remains strong and should ramp up in the second half of the ...

DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ -- According to MarketsandMarkets(TM), The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 billion by ...

Ratings for Krystal Biotech (NASDAQ:KRYS) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ...

Generate Biomedicines has announced the pricing of its initial public offering, implying a market value of about $2 billion for the U.S. biotechnology firm. The company, which specializes in designing ...

Although leasing sped up year-over-year, asking rents dropped and vacant move-in-ready lab space increased. The sluggish ...